Prevalence of multiple myeloma in patients on hemodialysis programs
Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante · 2025
DOI: 10.56867/106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante, 2025. Verfasst von David Garrido und 24 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Multiple myeloma (MM) is a hematological malignancy that often causes kidney failure, affecting more than 50% of MM patients. Kidney damage in MM is primarily due to cast nephropathy, light chain deposition disease, and amyloidosis. However, there are no data on MM patients undergoing hemodialysis in Ecuador. This study aims to report the prevalence of MM in the country's hemodialysis units.
Methods
This observational, descriptive, cross-sectional, multicenter study evaluated the prevalence of MM in hemodialysis patients in Ecuador. A survey was distributed to 23 nephrologists, collecting data on the total number of hemodialysis patients and those diagnosed with MM. Prevalence was calculated using the formula: Prevalence = (MM patients / Total hemodialysis patients) × 1000. Data were analyzed using nonparametric methods in R v4.3.2, with 99% confidence intervals. Results: were diagnosed with MM, yielding a prevalence of 1.1% (95% CI: 0.7% to 1.6%), or 11.3 cases per 1000 hemodialysis patients. The number of MM cases varied by city, with the highest number reported in Portoviejo (10 cases) and none in Riobamba.
Conclusion
The prevalence of MM in Ecuador is consistent with international reports, with similar findings in the United States (1.0%), Nigeria (0.81%), and other Latin American countries. These findings highlight the need for a national registry to better understand the needs of MM patients on hemodialysis.
Zitieren
APA
Garrido, D., Seminario, O., Santacruz, J., Moreira, E., Lituma, R., Moscoso, J., Rosales, U., Contreras, A. S., Ortega, V. H., Quevedo, A., Mora-Bravo, F., Tobar, S. S., Arias, D., Robles, W., Rodríguez, N., Chil, J. C. P., Mejía, C., Perez, A., Virla, G., …, & Huertas, J. (2025). Prevalence of multiple myeloma in patients on hemodialysis programs. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante. https://doi.org/10.56867/106
Vancouver
Garrido D, Seminario O, Santacruz J, Moreira E, Lituma R, Moscoso J, et al. Prevalence of multiple myeloma in patients on hemodialysis programs. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante. 2025. doi:10.56867/106
BibTeX
@article{Garrido2025,
author = {Garrido, David and Seminario, Omar and Santacruz, Juan and Moreira, Evelyn and Lituma, Rosalina and Moscoso, Jorge and Rosales, Ubelis and Contreras, Alfonso Silva and Ortega, Victor Hugo and Quevedo, Angel and Mora-Bravo, Franklin and Tobar, Santiago Silva and Arias, Daniel and Robles, Willan and Rodríguez, Norlán and Chil, Juan Carlos Perez and Mejía, Cristhian and Perez, Ailiyomar and Virla, Greysi and Muñoz, James and Paz, Juan Carlos and Baquero, Isabel Leon and Valarezo, Sandra and Osorio, Washington and Huertas, Jorge},
title = {Prevalence of multiple myeloma in patients on hemodialysis programs},
journal = {Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante},
year = {2025},
doi = {10.56867/106}
}
EUVIMED